AN UPTO DATE REVIEW: IN SIGHTS OF DIABETIC WOUND HEALING
Main Article Content
Keywords
diabetes mellitus, diabetic wounds, hyperglycemia, impaired wound healing, pathophysiology.
Abstract
Diabetes mellitus is a chronic metabolic condition characterized by persistent hyperglycemia, which has a detrimental impact on long-term health. The prevalence of diabetes mellitus is increasing, leading to a rise in the number of individuals experiencing impaired wound healing associated with this condition. Diabetic wounds often result in lower limb amputations, causing significant financial burden. The healing of these wounds is particularly challenging due to the hyperglycemic environment that promotes the growth of biofilms. This review provides an overview of recent advancements in the understanding of the pathophysiology of diabetic wounds, with a focus on neuropathy, impaired angiogenesis, compromised barrier function, and subsequent polymicrobial infections. The elucidation of these mechanisms contributes to a better understanding of the complexities involved in diabetic wound healing. Furthermore, this review discusses current treatment approaches as well as potential future strategies aimed at addressing the diverse pathologies associated with diabetic wounds. By targeting specific aspects of the wound healing process, these interventions aim to promote more efficient and effective healing, ultimately reducing the need for amputations and improving patient outcomes. Given the alarming increase in the prevalence of diabetes, it is crucial to stay updated on the advancements in our understanding of diabetic wound pathophysiology and the development of novel therapeutic approaches. Continued research and innovation in this field hold promise for improving the management and outcomes of individuals with diabetic wounds, thus alleviating the burden associated with this debilitating complication.
References
REFERENCES
1. Prentki M, Nolan CJ. Islet β cell failure in type 2 diabetes. The Journal of clinical investigation. 2006;116(7):1802-12.
2. Atlas D. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015. Eur Respir J. 2006;27:188-207.
3. Karri V, Gowthamarajan K, Satish Kumar M, Rajkumar M. Multiple biological actions of curcumin in the management of diabetic foot ulcer complications: a systematic review. Trop Med Surg. 2015;3(179):2.
4. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? Journal of diabetes investigation. 2011;2(1):18-32.
5. Kant V, Gopal A, Pathak NN, Kumar P, Tandan SK, Kumar D. Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats. International immunopharmacology. 2014;20(2):322-30.
6. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clinical infectious diseases. 2012;54(12):e132-e73.
7. Demidova-Rice TN, Durham JT, Herman IM. Wound healing angiogenesis: innovations and challenges in acute and chronic wound healing. Advances in wound care. 2012;1(1):17-22.
8. Ryckman C, Gilbert C, de Médicis R, Lussier A, Vandal K, Tessier PA. Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. Journal of leukocyte biology. 2004;76(2):433-40.
9. Busso N, So A. Gout. Mechanisms of inflammation in gout. Arthritis research & therapy. 2010;12(2):1-8.
10. Wang F, Huang D, Zhu W, Li S, Yan M, Wei M, et al. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats. International journal of molecular medicine. 2013;32(5):1037-46.
11. Huang D, Wang F-B, Guo M, Li S, Yan M-L, Yu T, et al. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats. International Journal of Molecular Medicine. 2015;35(3):829-38.
12. Gray RD, Lucas CD, MacKellar A, Li F, Hiersemenzel K, Haslett C, et al. Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps. Journal of inflammation. 2013;10(1):1-8.
13. Fadini GP, Menegazzo L, Rigato M, Scattolini V, Poncina N, Bruttocao A, et al. NETosis delays diabetic wound healing in mice and humans. Diabetes. 2016;65(4):1061-71.
14. Hanefeld M, Duetting E, Bramlage P. Cardiac implications of hypoglycaemia in patients with diabetes–a systematic review. Cardiovascular diabetology. 2013;12:1-11.
15. Deng L, Du C, Song P, Chen T, Rui S, Armstrong DG, et al. The role of oxidative stress and antioxidants in diabetic wound healing. Oxidative medicine and cellular longevity. 2021;2021.
16. Barker AR, Rosson GD, Dellon AL. Wound healing in denervated tissue. Annals of plastic surgery. 2006;57(3):339-42.
17. Azhar A, Basheer M, Abdelgawad MS, Roshdi H, Kamel MF. Prevalence of peripheral arterial disease in diabetic foot ulcer patients and its impact in limb salvage. The International Journal of Lower Extremity Wounds. 2021:15347346211027063.
18. Gazzaruso C, Gallotti P, Pujia A, Montalcini T, Giustina A, Coppola A. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study. Endocrine. 2021;71:59-68.
19. Iacopi E, Coppelli A, Goretti C, Bargellini I, Cicorelli A, Cioni R, et al. Effect of direct endovascular revascularization based on the angiosome model on risk of major amputations and life expectancy in type 2 diabetic patients with critical limb ischemia and foot ulceration. Journal of the American Podiatric Medical Association. 2021;111(4).
20. Caetano AP, Conde Vasco I, Veloso Gomes F, Costa NV, Luz JH, Spaepen E, et al. Successful revascularization has a significant impact on limb salvage rate and wound healing for patients with diabetic foot ulcers: single-centre retrospective analysis with a multidisciplinary approach. CardioVascular and Interventional Radiology. 2020;43:1449-59.
21. Alexandrescu V-A, Brochier S, Limgba A, Balthazar S, Khelifa H, De Vreese P, et al. Healing of diabetic neuroischemic foot wounds with vs without wound-targeted revascularization: preliminary observations from an 8-year prospective dual-center registry. Journal of Endovascular Therapy. 2020;27(1):20-30.
22. Los-Stegienta A, Katarzynska J, Borkowska A, Marcinek A, Cypryk K, Gebicki J. Differentiation of diabetic foot ulcers based on stimulation of myogenic oscillations by transient ischemia. Vascular Health and Risk Management. 2021:145-52.
23. Shareef AM, Ahmedani MY, Waris N. Strong association of anemia in people with diabetic foot ulcers (DFUs): Study from a specialist foot care center. Pakistan Journal of Medical Sciences. 2019;35(5):1216.
24. Olgun ME, Altuntaş SÇ, Sert M, Tetiker T. Anemia in patients with diabetic foot ulcer: effects on diabetic microvascular complications and related conditions. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2019;19(7):985-90.
25. Idris I, Tohid H, Muhammad NA, Rashid MRA, Ahad AM, Ali N, et al. Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study. BMJ open. 2018;8(12):e025125.
26. Alsayegh F, Waheedi M, Bayoud T, Al Hubail A, Al-Refaei F, Sharma P. Anemia in diabetes: experience of a single treatment center in Kuwait. Primary care diabetes. 2017;11(4):383-8.
27. Wright J, Oddy M, Richards T. Presence and characterisation of anaemia in diabetic foot ulceration. Anemia. 2014;2014.
28. Almoznino-Sarafian D, Shteinshnaider M, Tzur I, Bar-Chaim A, Iskhakov E, Berman S, et al. Anemia in diabetic patients at an internal medicine ward: clinical correlates and prognostic significance. European journal of internal medicine. 2010;21(2):91-6.
29. Yammine K, Hayek F, Assi C. Is there an association between anemia and diabetic foot ulcers? A systematic review and meta‐analysis. Wound Repair and Regeneration. 2021;29(3):432-42.
30. Boireau‐Adamezyk E, Baillet‐Guffroy A, Stamatas GN. The stratum corneum water content and natural moisturization factor composition evolve with age and depend on body site. Wiley Online Library; 2021.
31. Rigal A, Michael‐Jubeli R, Nkengne A, Baillet‐Guffroy A, Bigouret A, Tfayli A. Raman confocal microscopy and biophysics multiparametric characterization of the skin barrier evolution with age. Journal of Biophotonics. 2021;14(9):e202100107.
32. Park HY, Kim JH, Jung M, Chung CH, Hasham R, Park CS, et al. A long‐standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Experimental dermatology. 2011;20(12):969-74.
33. Lai C, Md Nor N, Kamaruddin N, Jamil A, Safian N. Comparison of transepidermal water loss and skin hydration in diabetics and nondiabetics. Clinical and experimental dermatology. 2021;46(1):58-64.
34. Sakai S, Kikuchi K, Satoh J, Tagami H, Inoue S. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. British Journal of Dermatology. 2005;153(2):319-23.
35. Ibuki A, Kuriyama S, Toyosaki Y, Aiba M, Hidaka M, Horie Y, et al. Aging-like physiological changes in the skin of Japanese obese diabetic patients. SAGE Open Medicine. 2018;6:2050312118756662.
36. Lee T-Y, Kim K-B, Han S-K, Jeong S-H, Dhong E-S. Skin hydration level as a predictor for diabetic wound healing: a retrospective study. Plastic and reconstructive surgery. 2019;143(4):848e-56e.
37. Namgoong S, Yang J-P, Han S-K, Lee Y-N, Dhong ES. Influence of peripheral neuropathy and microangiopathy on skin hydration in the feet of patients with diabetes mellitus. Wounds. 2019;31(7):173-8.
38. Rivas-Santiago B, Trujillo V, Montoya A, Gonzalez-Curiel I, Castañeda-Delgado J, Cardenas A, et al. Expression of antimicrobial peptides in diabetic foot ulcer. Journal of dermatological science. 2012;65(1):19-26.
39. Jagadeesh AT, Prakash PY, Rao NK, Ramya V. Culture characterization of the skin microbiome in Type 2 diabetes mellitus: A focus on the role of innate immunity. Diabetes Research and Clinical Practice. 2017;134:1-7.
40. Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine. 2019;66:526-37.
41. Ahmed A, Getti G, Boateng J. Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers. Drug Delivery and Translational Research. 2018;8:1751-68.
42. Shen J-H, Liu C-J, Lo S-C, Chen Y-T, Chang C-C. Topical therapy as adjuvant treatment to save a limb with critical ischemia from extensive and deep diabetic foot infection when revascularization is not feasible. Journal of Wound, Ostomy and Continence Nursing. 2016;43(2):197-201.
43. Greener B, Hughes A, Bannister N, Douglass J. Proteases and pH in chronic wounds. Journal of wound care. 2005;14(2):59-61.
44. McArdle CD, Lagan KM, McDowell DA. Effects of pH on the antibiotic resistance of bacteria recovered from diabetic foot ulcer fluid: an in vitro study. Journal of the American Podiatric Medical Association. 2018;108(1):6-11.
45. MacLeod AS, Mansbridge JN. The innate immune system in acute and chronic wounds. Advances in wound care. 2016;5(2):65-78.
46. Guo Sa, DiPietro LA. Factors affecting wound healing. Journal of dental research. 2010;89(3):219-29.
47. Mi Q, Rivière B, Clermont G, Steed DL, Vodovotz Y. Agent‐based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor‐β1. Wound Repair and Regeneration. 2007;15(5):671-82.
48. Richard C, Wadowski M, Goruk S, Cameron L, Sharma AM, Field CJ. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Research and Care. 2017;5(1):e000379.
49. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23(1):9-15.
50. Bybee JD, Rogers DE. The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. The Journal of laboratory and clinical medicine. 1964;64(1):1-13.
51. Alosaimi FD, Labani R, Almasoud N, Alhelali N, Althawadi L, AlJahani DM. Associations of foot ulceration with quality of life and psychosocial determinants among patients with diabetes; a case-control study. Journal of Foot and Ankle Research. 2019;12(1):1-11.
52. Fejfarová V, Jirkovská A, Dragomirecká E, Game F, Bém R, Dubský M, et al. Does the diabetic foot have a significant impact on selected psychological or social characteristics of patients with diabetes mellitus? Journal of Diabetes Research. 2014;2014.
53. Wukich DK, Ahn J, Raspovic KM, La Fontaine J, Lavery LA. Improved quality of life after transtibial amputation in patients with diabetes-related foot complications. The international journal of lower extremity wounds. 2017;16(2):114-21.
54. Simson U, Nawarotzky U, Friese G, Porck W, Schottenfeld‐Naor Y, Hahn S, et al. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome. Diabetic Medicine. 2008;25(2):206-12.
55. Bellingeri A, Falciani F, Traspedini P, Moscatelli A, Russo A, Tino G, et al. Effect of a wound cleansing solution on wound bed preparation and inflammation in chronic wounds: a single-blind RCT. Journal of Wound Care. 2016;25(3):160-8.
56. Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Annals of the New York Academy of Sciences. 2018;1411(1):153-65.
57. Steed DL, Attinger C, Colaizzi T, Crossland M, Franz M, Harkless L, et al. Guidelines for the treatment of diabetic ulcers. 2006.
58. Lebrun E, Tomic‐Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Wound repair and regeneration. 2010;18(5):433-8.
59. Elraiyah T, Domecq JP, Prutsky G, Tsapas A, Nabhan M, Frykberg RG, et al. A systematic review and meta-analysis of débridement methods for chronic diabetic foot ulcers. Journal of vascular surgery. 2016;63(2):37S-45S. e2.
60. Durante C, Greco A, Sidoli O, Maino C, Gallarini A, Ciprandi G. Evaluation of the effectiveness of a polyhexanide and propyl betaine-based gel in the treatment of chronic wounds. Minerva Chir. 2014;69(5):283-92.
61. Erdoğan A, Düzgün AP, Erdoğan K, Özkan MB, Coşkun F. Efficacy of hyperbaric oxygen therapy in diabetic foot ulcers based on Wagner classification. The journal of foot and ankle surgery. 2018;57(6):1115-9.
62. Irawan H, Semadi IN, Widiana I. A pilot study of short-duration hyperbaric oxygen therapy to improve HbA1c, leukocyte, and serum creatinine in patients with diabetic foot ulcer Wagner 3-4. The Scientific World Journal. 2018;2018.
63. Baiula M, Greco R, Ferrazzano L, Caligiana A, Hoxha K, Bandini D, et al. Integrin-mediated adhesive properties of neutrophils are reduced by hyperbaric oxygen therapy in patients with chronic non-healing wound. PLoS One. 2020;15(8):e0237746.
64. Hunter P, Greco E, Cross K, Perry J. Topical Oxygen Therapy Shifts Microbiome Dynamics in Chronic Diabetic Foot Ulcers. Wounds: a compendium of clinical research and practice. 2020;32(3):81-5.
65. Hayes P, Alzuhir N, Curran G, Loftus I. Topical oxygen therapy promotes the healing of chronic diabetic foot ulcers: a pilot study. Journal of wound care. 2017;26(11):652-60.
66. Fernando ME, Crowther RG, Pappas E, Lazzarini PA, Cunningham M, Sangla KS, et al. Plantar pressure in diabetic peripheral neuropathy patients with active foot ulceration, previous ulceration and no history of ulceration: a meta-analysis of observational studies. PloS one. 2014;9(6):e99050.
67. Collings R, Freeman J, Latour JM, Paton J. Footwear and insole design features for offloading the diabetic at risk foot—A systematic review and meta‐analyses. Endocrinology, diabetes & metabolism. 2021;4(1):e00132.
68. Yammine K, Assi C. Surgery versus nonsurgical methods in treating neuropathic plantar forefoot ulcers: a meta-analysis of comparative studies. The International Journal of Lower Extremity Wounds. 2022;21(1):7-17.
69. Bodnar RJ. Epidermal growth factor and epidermal growth factor receptor: the Yin and Yang in the treatment of cutaneous wounds and cancer. Advances in wound care. 2013;2(1):24-9.
70. Pierce G, Tarpley J, Yanagihara D, Mustoe T, Fox G, Thomason A. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. The American journal of pathology. 1992;140(6):1375.
71. Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP, Group ODUS. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Advances in skin & wound care. 2005;18(5):258-66.
72. LeGrand EK. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. The American journal of surgery. 1998;176(2):48S-54S.
73. Berlanga-Acosta J, Fernández-Montequín J, Valdés-Pérez C, Savigne-Gutiérrez W, Mendoza-Marí Y, García-Ojalvo A, et al. Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome. BioMed research international. 2017;2017.
74. Prats P, Duconge J, Valenzuela C, Berlanga J, Edrosa C, Fernandez‐Sanchez E. Disposition and receptor‐site binding of 125I‐EGF after topical administration to skin wounds. Biopharmaceutics & drug disposition. 2002;23(2):67-76.
75. Bi H, Li H, Zhang C, Mao Y, Nie F, Xing Y, et al. Stromal vascular fraction promotes migration of fibroblasts and angiogenesis through regulation of extracellular matrix in the skin wound healing process. Stem cell research & therapy. 2019;10:1-21.
76. Deng C, Wang L, Feng J, Lu F. Treatment of human chronic wounds with autologous extracellular matrix/stromal vascular fraction gel: A STROBE-compliant study. Medicine. 2018;97(32).
77. Snyder D, Sullivan N, Margolis D, Schoelles K. Skin substitutes for treating chronic wounds. 2020.
78. Gordon AJ, Alfonso AR, Nicholson J, Chiu ES. Evidence for healing diabetic foot ulcers with biologic skin substitutes: a systematic review and meta-analysis. Annals of plastic surgery. 2019;83(4S):S31-S44.
79. Steinberg JS, Edmonds M, Hurley DP, King WN. Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers. Journal of the American Podiatric Medical Association. 2010;100(1):73-7.
80. Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. Platelets. 2013;24(3):173-82.
81. Elsaid A, El-Said M, Emile S, Youssef M, Khafagy W, Elshobaky A. Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers. World journal of surgery. 2020;44:1294-301.
82. Lonardi R, Leone N, Gennai S, Trevisi Borsari G, Covic T, Silingardi R. Autologous micro-fragmented adipose tissue for the treatment of diabetic foot minor amputations: a randomized controlled single-center clinical trial (MiFrAADiF). Stem cell research & therapy. 2019;10(1):1-9.
83. Zhao L, Guo Z, Chen K, Yang W, Wan X, Zeng P, et al. Combined transplantation of mesenchymal stem cells and endothelial colony-forming cells accelerates refractory diabetic foot ulcer healing. Stem cells international. 2020;2020.
84. Crisologo PA, Davis KE, Ahn J, Farrar D, Van Asten S, La Fontaine J, et al. The infected diabetic foot: Can serum biomarkers predict osteomyelitis after hospital discharge for diabetic foot infections? Wound Repair and Regeneration. 2020;28(5):617-22.
85. Van Asten SA, Nichols A, La Fontaine J, Bhavan K, Peters EJ, Lavery LA. The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis. International wound journal. 2017;14(1):40-5.
86. Meloni M, Izzo V, Giurato L, Brocco E, Ferrannini M, Gandini R, et al. Procalcitonin is a prognostic marker of hospital outcomes in patients with critical limb ischemia and diabetic foot infection. Journal of Diabetes Research. 2019;2019.
87. Reiner MM, Khoury WE, Canales MB, Chmielewski RA, Patel K, Razzante MC, et al. Procalcitonin as a biomarker for predicting amputation level in lower extremity infections. The Journal of Foot and Ankle Surgery. 2017;56(3):484-91.
88. Vouillarmet J, Tordo J, Moret M, Michon P, Morelec I. 99mTc-white blood cell SPECT/CT to assess diabetic foot osteomyelitis remission: Contribution of semi-quantitative scoring system. Nuclear Medicine Communications. 2021;42(7):713-8.
89. Fernando ME, Woelfel SL, Perry D, Najafi B, Khan T, DuBourdieu C, et al. Dosing Activity and Return to Preulcer Function in Diabetes-Related Foot Ulcer Remission: Patient Recommendations and Guidance from the Limb Preservation Consortium at USC and the Rancho Los Amigos National Rehabilitation Center. Journal of the American Podiatric Medical Association. 2021;111(5).
90. Salvo P, Calisi N, Melai B, Dini V, Paoletti C, Lomonaco T, et al. Temperature-and pH-sensitive wearable materials for monitoring foot ulcers. International journal of nanomedicine. 2017;12:949.
1. Prentki M, Nolan CJ. Islet β cell failure in type 2 diabetes. The Journal of clinical investigation. 2006;116(7):1802-12.
2. Atlas D. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015. Eur Respir J. 2006;27:188-207.
3. Karri V, Gowthamarajan K, Satish Kumar M, Rajkumar M. Multiple biological actions of curcumin in the management of diabetic foot ulcer complications: a systematic review. Trop Med Surg. 2015;3(179):2.
4. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? Journal of diabetes investigation. 2011;2(1):18-32.
5. Kant V, Gopal A, Pathak NN, Kumar P, Tandan SK, Kumar D. Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats. International immunopharmacology. 2014;20(2):322-30.
6. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clinical infectious diseases. 2012;54(12):e132-e73.
7. Demidova-Rice TN, Durham JT, Herman IM. Wound healing angiogenesis: innovations and challenges in acute and chronic wound healing. Advances in wound care. 2012;1(1):17-22.
8. Ryckman C, Gilbert C, de Médicis R, Lussier A, Vandal K, Tessier PA. Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. Journal of leukocyte biology. 2004;76(2):433-40.
9. Busso N, So A. Gout. Mechanisms of inflammation in gout. Arthritis research & therapy. 2010;12(2):1-8.
10. Wang F, Huang D, Zhu W, Li S, Yan M, Wei M, et al. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats. International journal of molecular medicine. 2013;32(5):1037-46.
11. Huang D, Wang F-B, Guo M, Li S, Yan M-L, Yu T, et al. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats. International Journal of Molecular Medicine. 2015;35(3):829-38.
12. Gray RD, Lucas CD, MacKellar A, Li F, Hiersemenzel K, Haslett C, et al. Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps. Journal of inflammation. 2013;10(1):1-8.
13. Fadini GP, Menegazzo L, Rigato M, Scattolini V, Poncina N, Bruttocao A, et al. NETosis delays diabetic wound healing in mice and humans. Diabetes. 2016;65(4):1061-71.
14. Hanefeld M, Duetting E, Bramlage P. Cardiac implications of hypoglycaemia in patients with diabetes–a systematic review. Cardiovascular diabetology. 2013;12:1-11.
15. Deng L, Du C, Song P, Chen T, Rui S, Armstrong DG, et al. The role of oxidative stress and antioxidants in diabetic wound healing. Oxidative medicine and cellular longevity. 2021;2021.
16. Barker AR, Rosson GD, Dellon AL. Wound healing in denervated tissue. Annals of plastic surgery. 2006;57(3):339-42.
17. Azhar A, Basheer M, Abdelgawad MS, Roshdi H, Kamel MF. Prevalence of peripheral arterial disease in diabetic foot ulcer patients and its impact in limb salvage. The International Journal of Lower Extremity Wounds. 2021:15347346211027063.
18. Gazzaruso C, Gallotti P, Pujia A, Montalcini T, Giustina A, Coppola A. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study. Endocrine. 2021;71:59-68.
19. Iacopi E, Coppelli A, Goretti C, Bargellini I, Cicorelli A, Cioni R, et al. Effect of direct endovascular revascularization based on the angiosome model on risk of major amputations and life expectancy in type 2 diabetic patients with critical limb ischemia and foot ulceration. Journal of the American Podiatric Medical Association. 2021;111(4).
20. Caetano AP, Conde Vasco I, Veloso Gomes F, Costa NV, Luz JH, Spaepen E, et al. Successful revascularization has a significant impact on limb salvage rate and wound healing for patients with diabetic foot ulcers: single-centre retrospective analysis with a multidisciplinary approach. CardioVascular and Interventional Radiology. 2020;43:1449-59.
21. Alexandrescu V-A, Brochier S, Limgba A, Balthazar S, Khelifa H, De Vreese P, et al. Healing of diabetic neuroischemic foot wounds with vs without wound-targeted revascularization: preliminary observations from an 8-year prospective dual-center registry. Journal of Endovascular Therapy. 2020;27(1):20-30.
22. Los-Stegienta A, Katarzynska J, Borkowska A, Marcinek A, Cypryk K, Gebicki J. Differentiation of diabetic foot ulcers based on stimulation of myogenic oscillations by transient ischemia. Vascular Health and Risk Management. 2021:145-52.
23. Shareef AM, Ahmedani MY, Waris N. Strong association of anemia in people with diabetic foot ulcers (DFUs): Study from a specialist foot care center. Pakistan Journal of Medical Sciences. 2019;35(5):1216.
24. Olgun ME, Altuntaş SÇ, Sert M, Tetiker T. Anemia in patients with diabetic foot ulcer: effects on diabetic microvascular complications and related conditions. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2019;19(7):985-90.
25. Idris I, Tohid H, Muhammad NA, Rashid MRA, Ahad AM, Ali N, et al. Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study. BMJ open. 2018;8(12):e025125.
26. Alsayegh F, Waheedi M, Bayoud T, Al Hubail A, Al-Refaei F, Sharma P. Anemia in diabetes: experience of a single treatment center in Kuwait. Primary care diabetes. 2017;11(4):383-8.
27. Wright J, Oddy M, Richards T. Presence and characterisation of anaemia in diabetic foot ulceration. Anemia. 2014;2014.
28. Almoznino-Sarafian D, Shteinshnaider M, Tzur I, Bar-Chaim A, Iskhakov E, Berman S, et al. Anemia in diabetic patients at an internal medicine ward: clinical correlates and prognostic significance. European journal of internal medicine. 2010;21(2):91-6.
29. Yammine K, Hayek F, Assi C. Is there an association between anemia and diabetic foot ulcers? A systematic review and meta‐analysis. Wound Repair and Regeneration. 2021;29(3):432-42.
30. Boireau‐Adamezyk E, Baillet‐Guffroy A, Stamatas GN. The stratum corneum water content and natural moisturization factor composition evolve with age and depend on body site. Wiley Online Library; 2021.
31. Rigal A, Michael‐Jubeli R, Nkengne A, Baillet‐Guffroy A, Bigouret A, Tfayli A. Raman confocal microscopy and biophysics multiparametric characterization of the skin barrier evolution with age. Journal of Biophotonics. 2021;14(9):e202100107.
32. Park HY, Kim JH, Jung M, Chung CH, Hasham R, Park CS, et al. A long‐standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Experimental dermatology. 2011;20(12):969-74.
33. Lai C, Md Nor N, Kamaruddin N, Jamil A, Safian N. Comparison of transepidermal water loss and skin hydration in diabetics and nondiabetics. Clinical and experimental dermatology. 2021;46(1):58-64.
34. Sakai S, Kikuchi K, Satoh J, Tagami H, Inoue S. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. British Journal of Dermatology. 2005;153(2):319-23.
35. Ibuki A, Kuriyama S, Toyosaki Y, Aiba M, Hidaka M, Horie Y, et al. Aging-like physiological changes in the skin of Japanese obese diabetic patients. SAGE Open Medicine. 2018;6:2050312118756662.
36. Lee T-Y, Kim K-B, Han S-K, Jeong S-H, Dhong E-S. Skin hydration level as a predictor for diabetic wound healing: a retrospective study. Plastic and reconstructive surgery. 2019;143(4):848e-56e.
37. Namgoong S, Yang J-P, Han S-K, Lee Y-N, Dhong ES. Influence of peripheral neuropathy and microangiopathy on skin hydration in the feet of patients with diabetes mellitus. Wounds. 2019;31(7):173-8.
38. Rivas-Santiago B, Trujillo V, Montoya A, Gonzalez-Curiel I, Castañeda-Delgado J, Cardenas A, et al. Expression of antimicrobial peptides in diabetic foot ulcer. Journal of dermatological science. 2012;65(1):19-26.
39. Jagadeesh AT, Prakash PY, Rao NK, Ramya V. Culture characterization of the skin microbiome in Type 2 diabetes mellitus: A focus on the role of innate immunity. Diabetes Research and Clinical Practice. 2017;134:1-7.
40. Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine. 2019;66:526-37.
41. Ahmed A, Getti G, Boateng J. Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers. Drug Delivery and Translational Research. 2018;8:1751-68.
42. Shen J-H, Liu C-J, Lo S-C, Chen Y-T, Chang C-C. Topical therapy as adjuvant treatment to save a limb with critical ischemia from extensive and deep diabetic foot infection when revascularization is not feasible. Journal of Wound, Ostomy and Continence Nursing. 2016;43(2):197-201.
43. Greener B, Hughes A, Bannister N, Douglass J. Proteases and pH in chronic wounds. Journal of wound care. 2005;14(2):59-61.
44. McArdle CD, Lagan KM, McDowell DA. Effects of pH on the antibiotic resistance of bacteria recovered from diabetic foot ulcer fluid: an in vitro study. Journal of the American Podiatric Medical Association. 2018;108(1):6-11.
45. MacLeod AS, Mansbridge JN. The innate immune system in acute and chronic wounds. Advances in wound care. 2016;5(2):65-78.
46. Guo Sa, DiPietro LA. Factors affecting wound healing. Journal of dental research. 2010;89(3):219-29.
47. Mi Q, Rivière B, Clermont G, Steed DL, Vodovotz Y. Agent‐based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor‐β1. Wound Repair and Regeneration. 2007;15(5):671-82.
48. Richard C, Wadowski M, Goruk S, Cameron L, Sharma AM, Field CJ. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Research and Care. 2017;5(1):e000379.
49. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23(1):9-15.
50. Bybee JD, Rogers DE. The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. The Journal of laboratory and clinical medicine. 1964;64(1):1-13.
51. Alosaimi FD, Labani R, Almasoud N, Alhelali N, Althawadi L, AlJahani DM. Associations of foot ulceration with quality of life and psychosocial determinants among patients with diabetes; a case-control study. Journal of Foot and Ankle Research. 2019;12(1):1-11.
52. Fejfarová V, Jirkovská A, Dragomirecká E, Game F, Bém R, Dubský M, et al. Does the diabetic foot have a significant impact on selected psychological or social characteristics of patients with diabetes mellitus? Journal of Diabetes Research. 2014;2014.
53. Wukich DK, Ahn J, Raspovic KM, La Fontaine J, Lavery LA. Improved quality of life after transtibial amputation in patients with diabetes-related foot complications. The international journal of lower extremity wounds. 2017;16(2):114-21.
54. Simson U, Nawarotzky U, Friese G, Porck W, Schottenfeld‐Naor Y, Hahn S, et al. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome. Diabetic Medicine. 2008;25(2):206-12.
55. Bellingeri A, Falciani F, Traspedini P, Moscatelli A, Russo A, Tino G, et al. Effect of a wound cleansing solution on wound bed preparation and inflammation in chronic wounds: a single-blind RCT. Journal of Wound Care. 2016;25(3):160-8.
56. Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Annals of the New York Academy of Sciences. 2018;1411(1):153-65.
57. Steed DL, Attinger C, Colaizzi T, Crossland M, Franz M, Harkless L, et al. Guidelines for the treatment of diabetic ulcers. 2006.
58. Lebrun E, Tomic‐Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Wound repair and regeneration. 2010;18(5):433-8.
59. Elraiyah T, Domecq JP, Prutsky G, Tsapas A, Nabhan M, Frykberg RG, et al. A systematic review and meta-analysis of débridement methods for chronic diabetic foot ulcers. Journal of vascular surgery. 2016;63(2):37S-45S. e2.
60. Durante C, Greco A, Sidoli O, Maino C, Gallarini A, Ciprandi G. Evaluation of the effectiveness of a polyhexanide and propyl betaine-based gel in the treatment of chronic wounds. Minerva Chir. 2014;69(5):283-92.
61. Erdoğan A, Düzgün AP, Erdoğan K, Özkan MB, Coşkun F. Efficacy of hyperbaric oxygen therapy in diabetic foot ulcers based on Wagner classification. The journal of foot and ankle surgery. 2018;57(6):1115-9.
62. Irawan H, Semadi IN, Widiana I. A pilot study of short-duration hyperbaric oxygen therapy to improve HbA1c, leukocyte, and serum creatinine in patients with diabetic foot ulcer Wagner 3-4. The Scientific World Journal. 2018;2018.
63. Baiula M, Greco R, Ferrazzano L, Caligiana A, Hoxha K, Bandini D, et al. Integrin-mediated adhesive properties of neutrophils are reduced by hyperbaric oxygen therapy in patients with chronic non-healing wound. PLoS One. 2020;15(8):e0237746.
64. Hunter P, Greco E, Cross K, Perry J. Topical Oxygen Therapy Shifts Microbiome Dynamics in Chronic Diabetic Foot Ulcers. Wounds: a compendium of clinical research and practice. 2020;32(3):81-5.
65. Hayes P, Alzuhir N, Curran G, Loftus I. Topical oxygen therapy promotes the healing of chronic diabetic foot ulcers: a pilot study. Journal of wound care. 2017;26(11):652-60.
66. Fernando ME, Crowther RG, Pappas E, Lazzarini PA, Cunningham M, Sangla KS, et al. Plantar pressure in diabetic peripheral neuropathy patients with active foot ulceration, previous ulceration and no history of ulceration: a meta-analysis of observational studies. PloS one. 2014;9(6):e99050.
67. Collings R, Freeman J, Latour JM, Paton J. Footwear and insole design features for offloading the diabetic at risk foot—A systematic review and meta‐analyses. Endocrinology, diabetes & metabolism. 2021;4(1):e00132.
68. Yammine K, Assi C. Surgery versus nonsurgical methods in treating neuropathic plantar forefoot ulcers: a meta-analysis of comparative studies. The International Journal of Lower Extremity Wounds. 2022;21(1):7-17.
69. Bodnar RJ. Epidermal growth factor and epidermal growth factor receptor: the Yin and Yang in the treatment of cutaneous wounds and cancer. Advances in wound care. 2013;2(1):24-9.
70. Pierce G, Tarpley J, Yanagihara D, Mustoe T, Fox G, Thomason A. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. The American journal of pathology. 1992;140(6):1375.
71. Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP, Group ODUS. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Advances in skin & wound care. 2005;18(5):258-66.
72. LeGrand EK. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. The American journal of surgery. 1998;176(2):48S-54S.
73. Berlanga-Acosta J, Fernández-Montequín J, Valdés-Pérez C, Savigne-Gutiérrez W, Mendoza-Marí Y, García-Ojalvo A, et al. Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome. BioMed research international. 2017;2017.
74. Prats P, Duconge J, Valenzuela C, Berlanga J, Edrosa C, Fernandez‐Sanchez E. Disposition and receptor‐site binding of 125I‐EGF after topical administration to skin wounds. Biopharmaceutics & drug disposition. 2002;23(2):67-76.
75. Bi H, Li H, Zhang C, Mao Y, Nie F, Xing Y, et al. Stromal vascular fraction promotes migration of fibroblasts and angiogenesis through regulation of extracellular matrix in the skin wound healing process. Stem cell research & therapy. 2019;10:1-21.
76. Deng C, Wang L, Feng J, Lu F. Treatment of human chronic wounds with autologous extracellular matrix/stromal vascular fraction gel: A STROBE-compliant study. Medicine. 2018;97(32).
77. Snyder D, Sullivan N, Margolis D, Schoelles K. Skin substitutes for treating chronic wounds. 2020.
78. Gordon AJ, Alfonso AR, Nicholson J, Chiu ES. Evidence for healing diabetic foot ulcers with biologic skin substitutes: a systematic review and meta-analysis. Annals of plastic surgery. 2019;83(4S):S31-S44.
79. Steinberg JS, Edmonds M, Hurley DP, King WN. Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers. Journal of the American Podiatric Medical Association. 2010;100(1):73-7.
80. Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. Platelets. 2013;24(3):173-82.
81. Elsaid A, El-Said M, Emile S, Youssef M, Khafagy W, Elshobaky A. Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers. World journal of surgery. 2020;44:1294-301.
82. Lonardi R, Leone N, Gennai S, Trevisi Borsari G, Covic T, Silingardi R. Autologous micro-fragmented adipose tissue for the treatment of diabetic foot minor amputations: a randomized controlled single-center clinical trial (MiFrAADiF). Stem cell research & therapy. 2019;10(1):1-9.
83. Zhao L, Guo Z, Chen K, Yang W, Wan X, Zeng P, et al. Combined transplantation of mesenchymal stem cells and endothelial colony-forming cells accelerates refractory diabetic foot ulcer healing. Stem cells international. 2020;2020.
84. Crisologo PA, Davis KE, Ahn J, Farrar D, Van Asten S, La Fontaine J, et al. The infected diabetic foot: Can serum biomarkers predict osteomyelitis after hospital discharge for diabetic foot infections? Wound Repair and Regeneration. 2020;28(5):617-22.
85. Van Asten SA, Nichols A, La Fontaine J, Bhavan K, Peters EJ, Lavery LA. The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis. International wound journal. 2017;14(1):40-5.
86. Meloni M, Izzo V, Giurato L, Brocco E, Ferrannini M, Gandini R, et al. Procalcitonin is a prognostic marker of hospital outcomes in patients with critical limb ischemia and diabetic foot infection. Journal of Diabetes Research. 2019;2019.
87. Reiner MM, Khoury WE, Canales MB, Chmielewski RA, Patel K, Razzante MC, et al. Procalcitonin as a biomarker for predicting amputation level in lower extremity infections. The Journal of Foot and Ankle Surgery. 2017;56(3):484-91.
88. Vouillarmet J, Tordo J, Moret M, Michon P, Morelec I. 99mTc-white blood cell SPECT/CT to assess diabetic foot osteomyelitis remission: Contribution of semi-quantitative scoring system. Nuclear Medicine Communications. 2021;42(7):713-8.
89. Fernando ME, Woelfel SL, Perry D, Najafi B, Khan T, DuBourdieu C, et al. Dosing Activity and Return to Preulcer Function in Diabetes-Related Foot Ulcer Remission: Patient Recommendations and Guidance from the Limb Preservation Consortium at USC and the Rancho Los Amigos National Rehabilitation Center. Journal of the American Podiatric Medical Association. 2021;111(5).
90. Salvo P, Calisi N, Melai B, Dini V, Paoletti C, Lomonaco T, et al. Temperature-and pH-sensitive wearable materials for monitoring foot ulcers. International journal of nanomedicine. 2017;12:949.
Article Sidebar
Published
Aug 12, 2023
Article Details
How to Cite
VISHESH KUMAR MAURYA, Shweta Rawat, Ravinder Pal Singh, Abhilasha Mittal, & Sanjesh Kumar. (2023). AN UPTO DATE REVIEW: IN SIGHTS OF DIABETIC WOUND HEALING. Journal of Population Therapeutics and Clinical Pharmacology, 30(16), 586-598. https://doi.org/10.53555/jptcp.v30i16.2143
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
VISHESH KUMAR MAURYA
Assistant Professor, Rakshpal Bahadur, College of Pharmacy, Near Doordarshan Kendra/ITBP, Badaun Road, Bareilly, India
Shweta Rawat
Department of Pharmacology, NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur-303121
Ravinder Pal Singh
Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur- 303121
Abhilasha Mittal
Department of Pharmaceutical Chemistry, NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur-303121.
Sanjesh Kumar
Assistant Professor, Rakshpal Bahadur, College of Pharmacy, Near Doordarshan Kendra/ITBP, Badaun Road, Bareilly, India
How to Cite
VISHESH KUMAR MAURYA, Shweta Rawat, Ravinder Pal Singh, Abhilasha Mittal, & Sanjesh Kumar. (2023). AN UPTO DATE REVIEW: IN SIGHTS OF DIABETIC WOUND HEALING. Journal of Population Therapeutics and Clinical Pharmacology, 30(16), 586-598. https://doi.org/10.53555/jptcp.v30i16.2143